SCHEMBL79936

SCHEMBL79936

CC(=O)c1cc(Br)ccc1N

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
GLA P06280 1/20 0.68
MAPT P10636 3/20 0.59
POLB P06746 1/20 0.59
PLAU P00749 1/20 0.58
NPC1 O15118 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
PTGDR2 Q9Y5Y4 1/20 0.49
MAOA P21397 1/20 0.49
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CES2 O00748 1/20 0.45
GALR3 O60755 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
HDAC1 Q13547 1/20 0.43
ALDH1A1 P00352 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29560778 1.00 KDM4E (0.68) KDM4EGLAMAPTPOLBPLAU
SCHEMBL1189192 0.83 KDM4E (0.52) KDM4EGLAMAPTPOLBPLAU
Hydrochloric Acid SCHEMBL856910 0.82 KDM4E (0.50) KDM4EGLAMAPTPOLBPLAU
Methyl Alcohol SCHEMBL29017641 0.82 KDM4E (0.66) KDM4EGLAMAPTPOLBPLAU
SCHEMBL23118725 0.81 KDM4E (0.59) KDM4EGLAMAPTPOLBPLAU
SCHEMBL29622752 0.81 KDM4E (1.00) KDM4EGLAMAPTPOLBPLAU
SCHEMBL145485 0.81 KDM4E (1.00) KDM4EGLAMAPTPOLBPLAU
SCHEMBL147774 0.81 KDM4E (0.70) KDM4EGLAMAPTPOLBPLAU
SCHEMBL30864269 0.80 MAOA (0.53) KDM4EGLAMAPTPOLBHTT
SCHEMBL11575664 0.80 KDM4E (0.58) KDM4EGLAMAPTPOLBPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119012730-B All-inorganic perovskite solar cell based on 2-amino-5-bromoacetophenone interface modification and preparation method thereof 中国计量大学 2025-06-13 CN claimed
CN-119012730-A All-inorganic perovskite solar cell based on 2-amino-5-bromoacetophenone interface modification and preparation method thereof 中国计量大学 2024-11-22 CN claimed
US-8003784-B2 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same WYETH LLC (US) 2011-08-23 US claimed
US-20090306371-A1 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME WYETH (US) 2009-12-10 US claimed
EP-1756095-B1 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME WYETH CORP (US) 2008-05-21 EP claimed
EP-1756095-A2 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME Wyeth (US) 2007-02-28 EP claimed
WO-2005105739-A2 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME WYETH (US) 2005-11-10 WO claimed
US-20050239779-A1 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same WYETH (US) 2005-10-27 US claimed
US-12528796-B2 Modulators of RAS GTPase TOSK, INC. (US) 2026-01-20 US disclosed
US-20260008767-A1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2026-01-08 US disclosed
US-20250243194-A1 ANTAGONIST OF ADENOSINE RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2025-07-31 US disclosed
US-20250230169-A1 Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety CURIS INC (US) 2025-07-17 US disclosed
EP-4574210-A2 KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO The Scripps Research Institute (US) 2025-06-25 EP disclosed
CN-119012730-B All-inorganic perovskite solar cell based on 2-amino-5-bromoacetophenone interface modification and preparation method thereof 中国计量大学 2025-06-13 CN disclosed
WO-2004000801-A2 USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN TREATMENT OF HORMONE-RELATED CONDITIONS WYETH (US) 2003-12-31 WO disclosed
WO-2004000230-A2 CYCLOTHIOCARBAMATIVE DERIVATIVES AS PR MODULATORS AND USE THEREOF FOR TREATMENT OF SKIN DISORDERS WYETH (US) 2003-12-31 WO disclosed
US-5214059-A Dermatitis, psoriasis HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-05-25 US disclosed
US-5166170-A 2-(AMINOARYL) INDOLES AND INDOLINES AS TOPICAL ANTIINFLAMMATORY AGENTS FOR THE TREATMENT OF SKIN DISORDERS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-11-24 US disclosed
EP-0406734-A2 2-(Aminoaryl)indoles and indolines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-01-09 EP disclosed
US-3987047-A ANORETICS BOEHRINGER INGELHEIM GMBH (DT) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239779-A1 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same CBR3, MMAB, CTH KDM4E 398/4885GLA 2728/4885MAPT 4585/4885
US-20250230169-A1 Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety BAZ2A, BAZ2B, PI4KB KDM4E 868/4885GLA 2443/4885MAPT 3887/4885
US-20250243194-A1 ANTAGONIST OF ADENOSINE RECEPTORS ADORA2B, ADORA2A, ADORA1 KDM4E 3478/4885GLA 4261/4885MAPT 4767/4885
US-20090306371-A1 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME CBR3, CTH, MMAB KDM4E 385/4885GLA 2793/4885MAPT 4590/4885
US-20260008767-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR3, SSTR2 KDM4E 4278/4885GLA 2436/4885MAPT 4671/4885
US-12528796-B2 Modulators of RAS GTPase KRAS, NRAS, HRAS KDM4E 3816/4885GLA 1571/4885MAPT 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.